Thanks to @EUeic for selecting NIMBLE Diagnostics in our first attempt to receive the EIC Accelerator grant! This €2.5 million funding will help us achieve our next milestones in preparing our device for clinical trials in Europe.
Our Chief Technology Officer, Susana Amorós, has been honored with an #award for the best spin-off during the 25th-anniversary celebration hosted by @la_UPC. We are extremely proud to receive this #recognition and excited to continue to grow and develop the NIMBLE system.#MedTech
Our Chief Technology Officer, Susana Amorós, has been honored with an award for the best spin-off during the 25th-anniversary celebration hosted by @la_UPC . We are extremely proud to receive this recognition and excited to continue to grow and develop the NIMBLE system.
This past weekend, our CEO had the opportunity to present at the @BCNspiracy event, where he discussed the future of #Medical implants and how NIMBLE Diagnostics will play a vital role in #patient#diagnostics for millions. #MEDTECH
This article walks through the significance of #angiography and explores alternative methods that can determine whether a patient is experiencing coronary artery disease or #stent failure. https://t.co/PpesuSN6E5
Join NIMBLE Diagnostics on November 29th at the @bcndeeptech roundtable titled: ‘From 0 to 1: How to build a company from a PhD’. You can find our CTO, Susana Amorós, speaking about her experiences of building a #startup, like NIMBLE Diagnostics, in the main auditorium at 12:00.
We are excited to participate in the @4YFN_MWC taking place from February 26th to the 29th. This event is in partnership with the MWC Barcelona, one of the world's largest and most influential connectivity events, and you can find us within the Startup Corner UPC!
#startups
We are proud to announce that we have been accepted to take part in @bcndeeptech which takes place on the 28th and 29th of November 2023. We have been accepted to take part in the Start-Up Pitches Agenda and to have an exhibition booth!
🎉 Enhorabuena a las 47 empresas seleccionadas en el último corte de la convocatoria del #Acelerador del @EUeic#HorizonteEuropa.
🇪🇸 Y especialmente a las 3 empresas españolas que han conseguido financiación @peptomyc@DxNimble@quside 👏👏
Round of applause for the newest #eicAccelerator companies! 👏
🚀 47 companies from
🌍 15 countries are set to receive
💰 €349 million
Learn more about them and their game-changing #innovations here ➡️ https://t.co/B8U8UvuSfF
Round of applause for the newest #eicAccelerator companies! 👏
🚀 47 companies from
🌍 15 countries are set to receive
💰 €349 million
Learn more about them and their game-changing #innovations here ➡️ https://t.co/B8U8UvuSfF
NIMBLE Diagnostics is proud to announce that we have been #awarded the #EIC Accelerator grant in our very first submission, securing a non-dilutive compensation of €2.5 million. This recognition is one of the highest honors given by the European Commission to #MedTech startups!
After the introduction of #coronary stents, many #patients improved their quality of life after a #heart attack, but the journey doesn’t end there. Post-operative care is crucial to maximize the stent’s lifespan. Click the article below to learn more.
https://t.co/tCm9S5fCay
Coronary #stent monitoring can be a complex issue, and understanding the importance of following up with your #clinician can lead to better clinical outcomes. Below we discuss specific guidelines for how to monitor a stent after placement. #NIMBLE https://t.co/tOD8ZcfVYv
#Stents are remarkable medical devices that save lives every day. But, like any medical intervention, they aren't without their challenges. Check out this #article that walks us through the signs of stent failure that patients should be aware of. https://t.co/TMlqM9QONV
We are thrilled to announce that NIMBLE Diagnostics has been awarded the Best Innovation of 2023 by the #SITESymposium. This award reinforces our commitment to continue working tirelessly to bring novel technology to #cardiovascular#patients.
Our CEO and members of the NIMBLE Diagnostics team recently took a trip to #LasVegas to participate in the Mobile World Capital. Here we were able to demonstrate to our stakeholders the significant progress in our quest to make early #cardiovascular diagnosis accessible to all.